Interventional Recruiting Enrollment (Estimated) Enrollment 152 (Estimated)
View on ClinicalTrials.gov NCT06313684 Other Study ID: Fondecyt 1230787
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure Comprehensive Hybrid Cardiac Rehabilitation Trial to Assess Impact on Heart Failure Patients
First Submitted: March 4, 2024
Last Update Posted: December 3, 2024
Study duration (Estimated)
2 years 11 months 4 daysStudy Start
2024-04-01
Actual
Primary Completion
2026-09-01
Estimated
Study Completion
2027-03-01
Estimated
Study duration
2 years 11 months 4 days (Estimated)
Brief Summary
CO-CREATION-HF aims to evaluate the effectiveness of a comprehensive and hybrid cardiac rehabilitation model compared to supervised exercise alone.
Conditions
- Heart Failure NYHA Class II
- •
- Heart Failure NYHA Class III
Intervention / Treatment
- Other Comprehensive Initial Assessment
- Other Continuous evaluation
- Other Interval Exercise
- Behavioral Psychosocial support
- Other Diet management
- Other Resistance exercise
- Other Continuous exercise
- Other Initial Assessment
Contacts and Locations
Santiago
Chile
Complejo Hospitalario San José
Santiago
Chile
Hospital ClÃnico Universidad de Chile
Santiago
Chile
Hospital San Borja Arriarán
Temuco
Chile
Universidad de La Frontera
Participation Criteria
|
Sexes Eligible
|
Accepts Healthy Volunteers
|
Ages Eligible
|
|---|---|---|
| ALL | No | 18 Years and older |
Inclusion Criteria
• Meets HF diagnostic criteria of Guidelines
• On optimal tolerated medical therapy.
• Deemed by the treating physician as stable for at least 1 month.
• Able to attend the health center three times a week for the first month, and twice a week for the 2nd and 3rd months
• Owns a mobile phone
• Patient consents to participate in the study by signing an informed consent form.
Exclusion Criteria
• Decompensated thyroid disease.
• End-stage liver failure or Child-Pugh C.
• Cardiac device or cardiac surgery in the previous month or planned in the next 3 months.
• Patients with dyspnea predominantly of non-cardiac cause (e.g. COPD).
• Atrial fibrillation with a heart rate greater than 90 beats per minute at rest.
• Active neoplasm with life expectancy <2 years.
• Inclusion in another interventional study.
• Explicit contraindications to performing exercise.
• Comorbidities that preclude the patient from engaging in a CR program.
• Musculoskeletal or neurological disease that precludes the patient from performing exercise.
Participant Groups/Arms
Diseases
- Cardiovascular Diseases
Collaborators and Investigators
Keywords
- cardiac rehabilitation
- •
- heart failure
- •
- exercise
References
Outcome Measures
|
Outcome Measure
|
Measure Description
|
Time Frame
|
|---|---|---|
| Cardiorespiratory fitness | Will be assessed during a symptom-limited cardiopulmonary exercise test using an individualized gradual incremental ramp test designed to obtain oxygen consumption (VO2max). | Baseline, 6 months and 12 months. |
| Functional capacity | Will be assessed by the six-minute walk test (6MWT) | Baseline, 6 months and 12 months. |
| Health Related Quality of Life | Will be evaluated with the Minnesota Living with Heart Failure Questionnaire (MLHFQ). This questionnaire has 21 questions, which are answered on a scale of 1 to 5. The score of the questionnaire is obtained by the sum of the answers to the 21 questions, the higher the score, the worse the quality of life. | Baseline, 6 months and 12 months. |
|
Outcome Measure
|
Measure Description
|
Time Frame
|
|---|---|---|
|
|
|
|
| Program adherence and completion | Program adherence is defined as the percentage of total prescribed sessions completed. For home-based activities, the percentage of activities carried out at home of the prescribed ones will be computed. | 6 months |
| Concentration of Pro-B-type Natriuretic Peptide | Biomarker with prognostic utility. When it is higher than 1000 pg/mL, there is a higher probability of having events such as hospitalizations. | Baseline, 6 months and 12 months. |
| Functioning | Defined as the ability to perform basic, instrumental and advanced activities of daily living. It will be measured with the Activities of Daily Living Questionnaire - Technology (ADLQ-T). This questionnaire evaluates 7 areas: self-care (6 items), home care and management (6 items), work and recreation (4 items), shopping and money (3 items), travel (3), communication (5 items) and technology (5 items). Each item has a score, where 0 is no problem for the activity up to 3 indicating that he/she cannot perform the activity. The functional deficit is calculated for each area and for the overall questionnaire with the sum of all scores, divided by 3 and then multiplied by the total number of items answered. A higher score indicates greater impairment of ADLs. | Baseline, 6 months and 12 months. |
| Mortality and Hospital admission | Will be measured as a composite outcome. It will be measured as a composite outcome. An adjudicating committee will confirm the events that will be expressed as the number of participants hospitalized or dead and their respective causes. All-cause and HF-specific mortality and hospitalization will be differentiated. | 12 months |
| Upper-body muscle strength | Will be assessed through grip strength performed with a Jamar® Plus+ electronic handheld dynamometer. the result shall be expressed in kilograms. | Baseline, 6 months and 12 months. |
| Lower-body muscle strength | Will be assessed through the chair stand test, with the participant in a seated position in a chair. From this position, they will be directed to rise fully and return to the starting position as many times as possible over 30 seconds. The number of repetitions achieved will be recorded | Baseline, 6 months and 12 months. |
| Cost | Will be assessed through micro-costing from the health care system perspective. Also out-of-pocket spending by patients will be costed | 6 months |